Scotiabank Maintains Sector Outperform on Merck & Co, Raises Price Target to $155

Benzinga Newsdesk www.benzinga.com Positive 90.1%

Neg 0% Neu 0% Pos 90.1%

Scotiabank analyst Louise Chen maintains Merck & Co (NYSE:MRK) with a Sector Outperform and raises the price target from $136 to $155.